Muscle Proteome Analysis of Facioscapulohumeral Dystrophy Patients Reveals a Metabolic Rewiring Promoting Oxidative/Reductive Stress Contributing to the Loss of Muscle Function
Facioscapulohumeral muscular dystrophy (FSHD) is caused by the epigenetic de-repression of the double homeobox 4 (DUX4) gene, leading to asymmetric muscle weakness and atrophy that begins in the facial and scapular muscles and progresses to the lower limbs. This incurable condition can severely impa...
Saved in:
| Main Authors: | Manuela Moriggi, Lucia Ruggiero, Enrica Torretta, Dario Zoppi, Beatrice Arosio, Evelyn Ferri, Alessandra Castegna, Chiara Fiorillo, Cecilia Gelfi, Daniele Capitanio |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2024-11-01
|
| Series: | Antioxidants |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2076-3921/13/11/1406 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Genetics of Facioscapulohumeral Muscular Dystrophy
by: J Gordon Millichap
Published: (1991-11-01) -
Quantitative Three-dimensional Scanning of Facial Movements in Facioscapulohumeral Dystrophy
by: Ceren Hangul, et al.
Published: (2025-04-01) -
Speech and swallowing characteristics in patients with facioscapulohumeral muscular dystrophy
by: Vanessa Brzoskowski dos SANTOS, et al.
Published: (2022-02-01) -
Facioscapulohumeral muscular dystrophy: a review of pathogenesis, clinical symptoms, and treatment
by: T. Mikalauskas, et al.
Published: (2023-10-01) -
Therapeutic Strategy and Clinical Path of Facioscapulohumeral Muscular Dystrophy: Review of the Current Literature
by: Qi Xie, et al.
Published: (2024-09-01)